Scandinavian ChemoTech AB Series B Net Asset Momentum
Scandinavian ChemoTech AB Series B net asset momentum. Scandinavian ChemoTech AB Series B (CMOTEC-B) recorded a net asset momentum of -46.7% as of December 2025, with net assets of Skr3.19 Million SEK. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Explore Scandinavian ChemoTech AB Series B (CMOTEC-B) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
YoY Momentum
Current Net Assets
Years of Data
Country
Net Asset Momentum of Scandinavian ChemoTech AB Series B (2014–2025)
Net asset momentum of Scandinavian ChemoTech AB Series B from 2014 to 2025. This chart tracks Scandinavian ChemoTech AB Series B's year-over-year net asset growth across 12 annual reporting periods from 2014 to 2025. The most recent momentum reading is -46.7%, with net assets of Skr3.19 Million SEK as of December 2025. See shareholders equity of Scandinavian ChemoTech AB Series B for net asset value and shareholders' equity analysis.
Scandinavian ChemoTech AB Series B Net Asset Momentum by Year (2014–2025)
Scandinavian ChemoTech AB Series B net asset momentum by year from 2014 to 2025. The table below shows the complete annual net asset history for Scandinavian ChemoTech AB Series B from 2014 to 2025, covering 12 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see CMOTEC-B stock market capitalisation.
| Year | Net Assets (SEK) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | Skr3.19 Million | Skr13.20 Million | Skr10.01 Million | ▼ -46.7% |
| 2024 | Skr5.98 Million | Skr13.38 Million | Skr7.40 Million | ▼ -45.8% |
| 2023 | Skr11.03 Million | Skr14.87 Million | Skr3.84 Million | ▼ -21.2% |
| 2022 | Skr13.99 Million | Skr21.70 Million | Skr7.71 Million | ▼ -41.5% |
| 2021 | Skr23.92 Million | Skr25.81 Million | Skr1.89 Million | ▲ +159.0% |
| 2020 | Skr9.24 Million | Skr15.99 Million | Skr6.75 Million | ▼ -5.1% |
| 2019 | Skr9.73 Million | Skr17.49 Million | Skr7.76 Million | ▼ -52.5% |
| 2018 | Skr20.50 Million | Skr22.81 Million | Skr2.31 Million | ▲ +99.2% |
| 2017 | Skr10.29 Million | Skr12.84 Million | Skr2.56 Million | ▼ -29.5% |
| 2016 | Skr14.58 Million | Skr16.83 Million | Skr2.24 Million | ▲ +1578.9% |
| 2015 | Skr868.64K | Skr6.65 Million | Skr5.78 Million | ▲ +1777.4% |
| 2014 | Skr46.27K | Skr65.90K | Skr19.63K | — |